NYSE

Evommune, Inc. (EVMN)

♥ 597 Thanks from members

Live price chart, market sentiment, and community perspectives for Evommune, Inc. (NYSE: EVMN).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Biotech ScientistsLeadership: David Perry (CEO)Holder: Life Science Venture FundsImmunology TherapeuticsBiopharmaceuticals#EVMN#Evommune#Biotech#NYSE#Clinical Stage